<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Entasis Therapeutics Holdings Inc.

    Entasis Therapeutics Holdings Inc.

    Entasis is a clinical-stage biopharmaceutical company focused on the discovery, de...

    Entasis is a clinical-stage biopharmaceutical c...

    Filing Type:    PU
    Sol-Gel Technologies Ltd.

    Sol-Gel Technologies Ltd.

    Sol-Gel is a clinical-stage specialty pharmaceutical company focused on developing...

    Sol-Gel is a clinical-stage specialty pharmaceu...

    Filing Type:    PU
    Akorn, Inc.

    Akorn, Inc.

    Akorn, Inc. is a niche pharmaceutical company that develops, manufactures and mark...

    Akorn, Inc. is a niche pharmaceutical company t...

    Filing Type:    PU
    Akari Therapeutics Plc

    Akari Therapeutics Plc

    Akari is a biopharmaceutical company focused on developing inhibitors of acute and...

    Akari is a biopharmaceutical company focused on...

    Filing Type:    PU
    MyoKardia, Inc.

    MyoKardia, Inc.

    MyoKardia is a clinical-stage biopharmaceutical company pioneering a precision med...

    MyoKardia is a clinical-stage biopharmaceutical...

    Filing Type:    PU
    Athenex, Inc.

    Athenex, Inc.

    Athenex is a global oncology focused biopharmaceutical company dedicated to the di...

    Athenex is a global oncology focused biopharmac...

    Filing Type:    PU
    Morphic Holding, Inc.

    Morphic Holding, Inc.

    Morphic Therapeutic is leading the development of a new generation of oral integri...

    Morphic Therapeutic is leading the development ...

    Filing Type:    PU
    Sunesis Pharmaceuticals, Inc.

    Sunesis Pharmaceuticals, Inc.

    Sunesis is a biopharmaceutical company focused on the development and commercializ...

    Sunesis is a biopharmaceutical company focused ...

    Filing Type:    PU
    ESSA Pharma Inc.

    ESSA Pharma Inc.

    With a focus on the development of small molecule drugs for the treatment of cance...

    With a focus on the development of small molecu...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.